Global Healthcare: Standing at The Crossroads of Healthcare and AI SMID Cap BioTech

Overall, we see AI evolving from a productivity tool into a broader strategic enabler for SMID-cap biotech. The near-term benefits are likely to come from workflow automation and improved access to data, while the longer-term opportunity lies in accelerating discovery, improving candidate selection, and addressing bottlenecks such as patient recruitment. Ultimately, the greatest value is likely to come from selectively applying AI where high-quality data are available and the resulting outputs can be rigorously validated. The technology is advancing quickly, but scientific expertise, human judgment, and strong governance will remain central to how successfully it is adopted.